Valuation: Meilleure Health International Industry Group Limited

Market Cap 681M 86.84M 78.89M 72.89M 65.84M 124M 8.15B 129M 877M 347M 4.38B 326M 319M 13.86B P/E 2024
36.7x
P/E 2025 28.5x
Enterprise Value 1.05B 134M 121M 112M 101M 191M 12.56B 198M 1.35B 535M 6.74B 502M 491M 21.34B EV / Sales 2024
28.8x
EV / Sales 2025 39.6x
Free-Float
30.87%
Yield 2024
1.38%
Yield 2025 2.08%
09-21 Meilleure Health to Acquire Property Investment Company MT
09-21 Meilleure Health International Industry Group Limited agreed to acquire Tech-Medi Development Limited from Zhou Xuzhou for HKD 35.2 million. CI
08-27 Meilleure Health International Industry Group Limited Reports Earnings Results for the Half Year Ended June 30, 2026 CI
08-27 Meilleure Health International Industry Group Limited Announces Interim (Semi-Annual) Ordinary Cash Dividend for the Six Months Ended 30 June 2026, Payable on 30 September 2026 CI
07-22 Meilleure Health International Industry Group Limited Announces Change of Registered Office Address in Hamilton CI
07-07 Meilleure Health Forecasts Rise in H1 Profit MT
07-07 Meilleure Health International Industry Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2026 CI
06-26 Meilleure Health International Industry Group Limited Approves Final Dividend for the Financial Year Ended 31 December 2025 CI
03-27 Meilleure Health International Industry Group Limited Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-27 Meilleure Health International Industry Group Limited Recommends Payment of Final Dividend for the Year Ended December 31, 2025, Payable on August 28, 2026 CI
01-09 Meilleure Health to Acquire Chinese Property Leasing Firm for HK$137 Million MT
01-08 Meilleure Health International Industry to buy Jiangsu Yide for RMB124.8 million RE
01-08 Meilleure Health International Industry Group Limited signed a Equity Interest Transfer Agreement to acquire Jiangsu Yide Investment Company Limited from Zhou Chuan and Tan Wensheng for approximately CNY 120 million. CI
1 week-0.59%
Current month-1.18%
1 month-11.11%
3 months-30.00%
6 months-42.07%
Current year-36.60%
1 week 0.17
Extreme 0.168
0.17
1 month 0.16
Extreme 0.159
0.18
Current year 0.16
Extreme 0.159
0.3
1 year 0.16
Extreme 0.159
0.3
3 years 0.11
Extreme 0.106
0.32
5 years 0.11
Extreme 0.106
0.48
10 years 0.11
Extreme 0.106
1.64
Manager TitleAgeSince
Chief Executive Officer 43 30/08/2013
Corporate Secretary 34 31/12/2025
Corporate Secretary 33 31/12/2025
Director TitleAgeSince
Chairman 70 30/08/2013
Director/Board Member 43 30/08/2013
Director/Board Member 64 30/08/2013
Date Insider Type Main position Quantity % Market Cap. Importance
11/09/26 Other

Chairman

840,000 0.0207%
14/07/26 Other

Chairman

780,000 0.0192%
08/07/26 Other

Chief Executive Officer

240,000 0.0059%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-0.59%-40.00%-32.80% 86.84M
-0.11%+2.09%+41.09%+144.84% 1,286B
-0.58%+0.77%+42.44%+89.39% 688B
+0.23%+0.84%+26.39%+113.88% 521B
+1.14%+2.04%+42.51%+72.81% 386B
-1.04%-1.74%+57.42%+43.33% 364B
+1.27%+1.72%+28.34%+63.11% 302B
+0.37%-0.23%+3.25%+38.05% 287B
+0.11%+0.16%+36.37%+73.23% 252B
+0.26%-0.46%+35.82%+126.17% 208B
Average +0.08%+1.81%+27.36%+73.20% 429B
Weighted average by Cap. -0.02%+3.26%+37.08%+99.13%

Financials

2024 2025
Net sales 50.68M 6.46M 5.87M 5.42M 4.9M 9.24M 606M 9.57M 65.2M 25.84M 325M 24.24M 23.72M 1.03B 36.52M 4.65M 4.23M 3.91M 3.53M 6.66M 437M 6.89M 46.99M 18.62M 235M 17.47M 17.1M 743M
Net income 32.48M 4.14M 3.76M 3.48M 3.14M 5.92M 389M 6.13M 41.79M 16.56M 209M 15.53M 15.21M 661M 37.98M 4.84M 4.4M 4.06M 3.67M 6.93M 455M 7.17M 48.87M 19.36M 244M 18.17M 17.78M 773M
Net Debt 273M 34.81M 31.63M 29.22M 26.4M 49.81M 3.27B 51.56M 351M 139M 1.75B 131M 128M 5.56B 368M 46.89M 42.6M 39.36M 35.55M 67.09M 4.4B 69.45M 473M 188M 2.36B 176M 172M 7.48B
Projected Income Statement - Annual - Meilleure Health International Industry Group Limited
Logo Meilleure Health International Industry Group Limited
Meilleure Health International Industry Group Ltd is an investment holding company mainly engaged in the production and sale of cannabis health products. The Company operates through four segments. The Healthcare-Related Business segment is engaged in health management services, medical beauty services, and sales of health-related products and Cannabidiol (CBD) downstream products. The Property-Related Business segment is engaged in real estate sales agency, investment property leasing, and residential property development and sales. The Trading Business segment is engaged in the trading of building materials and new energy products, the provision of new energy product procurement services, and health-related product sales agency services. The Equity Investment Business segment is engaged in the management of investment portfolio.
Employees
43
Date Price Change Volume
16/11/26 HK$0.1680 0.00% 0
13/11/26 HK$0.1680 -0.59% 0
12/11/26 HK$0.1690 0.00% 0
11/11/26 HK$0.1690 0.00% 0
10/11/26 HK$0.1690 0.00% 0
  1. Stock Market
  2. Stocks
  3. 2327 Stock